<thinking>
  The user is asking about mixing biology datasets with transformers and whether it's viable. This is a broad question about applying transformer models to biological data. I should provide a comprehensive, informative answer that covers:

1. The current state of transformers in biology (it's definitely viable and already happening)
2. Types of biological data where transformers are being used
3. Specific examples of successful applications
4. Key considerations and challenges
5. Practical advice for someone wanting to pursue this

I should be clear, accurate, and helpful. The user seems to be exploring an idea, so I should encourage them while also being realistic about challenges.

Let me structure this response:

**Introduction**: Yes, it's not just viable—it's a major trend in computational biology right now.

**Key Application Areas**:
- Genomics (DNA/RNA sequences)
- Proteins (sequences and structures)
- Single-cell transcriptomics
- Medical imaging (vision transformers)
- Clinical text (EHRs)
- Multi-modal integration

**Notable Examples**:
- DNABERT, Nucleotide Transformer
- ESM (Meta), ProtTrans, AlphaFold uses attention
- scBERT, Geneformer
- ClinicalBERT, BioClinicalBERT

**Challenges**:
- Data quality and standardization
- Interpretability
- Computational costs
- Domain expertise needed
- Data scarcity in some areas

**Practical Steps**:
- Start with pre-trained models
- Use existing libraries
- Consider data characteristics
- Collaborate with biologists
- Start small and validate

**Conclusion**: Very viable, but requires thoughtful approach.

I should avoid being overly technical but provide enough detail to be useful. I should also mention that this is an active area of research with many opportunities.

I don't need to use any tools for this—it's a knowledge-based question about the field that I can answer directly.
</thinking>

Yes, this is not just viable—it's one of the most active and promising frontiers in computational biology right now. Transformers are being successfully applied across virtually every type of biological data. Here's a breakdown:

### **Where It's Working**

**1. Biological Sequences (Most Mature)**
- **DNA/RNA**: Models like **DNABERT**, **Nucleotide Transformer**, and **HyenaDNA** analyze genomic sequences for gene finding, regulatory element prediction, and variant effect prediction. They treat DNA like a language.
- **Proteins**: **ESM (Evolutionary Scale Modeling)** from Meta and **ProtTrans** learn protein sequences for structure prediction, function annotation, and design. AlphaFold's Evoformer module is essentially a transformer architecture.

**2. Single-Cell Genomics**
- **scBERT** and **Geneformer** treat cells as "sentences" of expressed genes, enabling cell type classification, perturbation prediction, and disease modeling without labeled data.

**3. Clinical Data**
- **ClinicalBERT**, **BioClinicalBERT** extract insights from electronic health records (EHRs) for phenotyping, risk prediction, and clinical trial matching.

**4. Medical Imaging**
- Vision Transformers (ViTs) are competing with CNNs for radiology, pathology slides, and microscopy images.

**5. Multi-Omics Integration**
- Transformers naturally fuse disparate data (genomics, proteomics, imaging) by treating them as different "modalities" or "languages."

### **Key Advantages**
- **Long-range dependencies**: Capturing interactions far apart in sequences (e.g., enhancers far from genes)
- **Transfer learning**: Pre-training on massive unlabeled datasets (e.g., all known proteins) then fine-tuning on small specific tasks
- **Interpretability**: Attention weights can highlight biologically meaningful patterns (though this requires caution)

### **Realistic Challenges**
- **Data quality**: Biological data is noisy, biased, and often poorly standardized
- **Scale**: Genomic datasets can be enormous (human genome = 3B tokens). Specialized architectures (long-range transformers, Hyena) help
- **Interpretability**: Attention doesn't always equal biological mechanism
- **Cost**: Training from scratch is expensive; most projects fine-tune existing models
- **Domain expertise**: Success requires close collaboration with biologists to frame questions and validate results

### **Practical Starting Points**
- **Use pre-trained models**: Hugging Face has `DNABERT`, `ESM`, `scBERT` ready to fine-tune
- **Start small**: A binary classification task on a well-curated dataset (e.g., promoter vs. non-promoter sequences)
- **Leverage existing libraries**: `transformers`, `PyTorch`, `Scanpy` for single-cell
- **Validate experimentally**: Partner with a wet lab to test predictions

**Bottom line**: It's highly viable, but the magic is in *how* you adapt transformers to the specific biological question and data structure—not just applying them blindly. The field is moving fast, with new pre-trained models and benchmarks emerging monthly.